
LS 3X Long (3CON) | Stock Overview & Key Data
LS 3X Long Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €121.60 on March 25, 2024
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
LS 3X Long 3CON | N/A Micro-cap | 5.34% | 9.86% | -16.85% | 66.51% | -56.15% | -41.98% | -91.82% | -90.40% |
UBS AG, London 0022U | N/A Micro-cap | 0.09% | 0.47% | 3.30% | 3.04% | 3.93% | 8.73% | 24.56% | 24.56% |
GLDFP 100PRO0825U 0110U | N/A Micro-cap | 0.08% | 0.35% | 1.16% | 2.41% | 2.94% | 6.55% | 22.72% | 22.72% |
MSCIW 103PRO0226U 0119U | N/A Micro-cap | -0.02% | -0.02% | 1.62% | 3.24% | 4.61% | 6.94% | 19.67% | 19.67% |
Ark Genomic 1ARKG | N/A Micro-cap | 8.94% | 11.43% | 16.77% | 6.56% | -1.02% | 3.72% | -96.66% | -96.93% |
1Ark Innovation 1ARKK | N/A Micro-cap | 6.57% | 10.36% | 20.32% | 44.57% | 28.62% | 68.78% | 49.20% | 153.74% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is 3CON's 52-week high and low?
- In the last 52 weeks, LS 3X Long reached a high of €46.30 (on November 12, 2024) and a low of €1.12 (on April 7, 2025).
- What is the market cap and P/E ratio for 3CON?
- Curious about LS 3X Long's size and valuation? Its market capitalization stands at N/A. When it comes to valuation, the P/E ratio (trailing twelve months) is 1.80, and the forward P/E (looking ahead) is N/A.
- Does 3CON pay dividends? If so, what's the yield?
- As for dividends, LS 3X Long isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are LS 3X Long's main competitors or similar companies to consider before investing?
When looking at LS 3X Long, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return UBS AG, London
0022UN/A N/A N/A 8.73% 24.56% GLDFP 100PRO0825U
0110UN/A N/A N/A 6.55% 22.72% MSCIW 103PRO0226U
0119UN/A N/A N/A 6.94% 19.67% Ark Genomic
1ARKGN/A N/A N/A 3.72% -96.66% 1Ark Innovation
1ARKKN/A N/A N/A 68.78% 49.20% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for LS 3X Long Cryptocurrency Fund? (e.g., ROE, Debt/Equity)
- To get a sense of LS 3X Long's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 30.41%, the Debt to Equity ratio from the most recent quarter is 1.88, and its Gross Profit Margin stands at 38.53%.
- What is the recent revenue and earnings growth for 3CON?
- Looking at LS 3X Long's growth, its revenue over the trailing twelve months (TTM) was €7B. Compared to the same quarter last year (YoY), quarterly revenue grew by -2.60%, and quarterly earnings saw a YoY growth of N/A.
- How much of 3CON stock is held by insiders and institutions?
- Wondering who owns LS 3X Long stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.